Anne Moscona

Washington University in St. Louis

NIH Rank #661
  • Top 5% Funded
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$6.9M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#661
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $6.9M across 5 grants · National rank #661.

Top grants by award amount

Anne Moscona's NIH grant portfolio, ranked by award amount.

  • 1U19AI181984-01U19
    Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPP
    $5.2M
    award amount
  • 5R01AI175362-02R01
    Broad spectrum inhibitors of paramyxovirus envelope proteins
    $780.3K
    award amount
  • 4R01AI160961-04R01
    Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2
    $714.3K
    award amount
  • 3R01AI175362-02S1R01
    Broad spectrum inhibitors of paramyxovirus envelope proteins
    $106.5K
    award amount
  • 3R01AI175362-01S1R01
    Broad spectrum inhibitors of paramyxovirus envelope proteins
    $41.4K
    award amount

Affiliations

Institutions that have administered grants for Anne Moscona.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Washington University in St. Louis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #661
  7. 2024
    Entered Top 25% Nationally
    Ranked #661
  8. 2024
    Entered Top 10% Nationally
    Ranked #661
  9. 2024
    Entered Top 5% Nationally
    Ranked #661
  10. 2024
    Multi-Institutional Research
    Awards at 2 institutions